Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market definitions
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Unpaid sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Blood gas and electrolyte analyzers industry 360° synopsis, 2017 - 2028
2.1.1 Business trends
2.1.2 Modality trends
2.1.3 Product trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Blood Gas and Electrolyte Analyzers Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising prevalence of chronic disease worldwide
3.3.1.2 Technological advancements
3.3.1.3 Increasing demand for integrated system
3.3.1.4 Growing elderly population base in developed countries
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost associated with product
3.3.2.2 Complex regulatory scenario
3.4 Growth potential analysis
3.4.1 By modality
3.4.2 By product
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2021
3.7.1 Company matrix analysis, 2021
3.8 PESTEL analysis
Chapter 4 Blood Gas and Electrolyte Analyzers Market, By Modality
4.1 Key segment trends
4.2 Bench top
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Portable
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 Blood Gas and Electrolyte Analyzers Market, By Product
5.1 Key segment trends
5.2 Blood gas analyzers
5.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.3 Electrolyte analyzers
5.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.4 Combined analyzers
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
5.5 Consumables
5.5.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 Blood Gas and Electrolyte Analyzers Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market size, by region, 2017 - 2028 (USD Million)
6.3 Central laboratories
6.3.1 Market size, by region, 2017 - 2028 (USD Million)
6.4 Point-of-care
6.4.1 Market size, by region, 2017 - 2028 (USD Million)
6.5 Diagnostic centers
6.5.1 Market size, by region, 2017 - 2028 (USD Million)
6.6 Others
6.6.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 7 Blood Gas and Electrolyte Analyzers Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017 - 2028 (USD Million)
7.2.2 Market size, by modality, 2017 - 2028 (USD Million)
7.2.3 Market size, by product, 2017 - 2028 (USD Million)
7.2.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by modality, 2017 - 2028 (USD Million)
7.2.5.2 Market size, by product, 2017 - 2028 (USD Million)
7.2.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by modality, 2017 - 2028 (USD Million)
7.2.6.2 Market size, by product, 2017 - 2028 (USD Million)
7.2.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017 - 2028 (USD Million)
7.3.2 Market size, by modality, 2017 - 2028 (USD Million)
7.3.3 Market size, by product, 2017 - 2028 (USD Million)
7.3.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by modality, 2017 - 2028 (USD Million)
7.3.5.2 Market size, by product, 2017 - 2028 (USD Million)
7.3.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by modality, 2017 - 2028 (USD Million)
7.3.6.2 Market size, by product, 2017 - 2028 (USD Million)
7.3.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.7 France
7.3.7.1 Market size, by modality, 2017 - 2028 (USD Million)
7.3.7.2 Market size, by product, 2017 - 2028 (USD Million)
7.3.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.8 Spain
7.3.8.1 Market size, by modality, 2017 - 2028 (USD Million)
7.3.8.2 Market size, by product, 2017 - 2028 (USD Million)
7.3.8.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.3.9 Italy
7.3.9.1 Market size, by modality, 2017 - 2028 (USD Million)
7.3.9.2 Market size, by product, 2017 - 2028 (USD Million)
7.3.9.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017 - 2028 (USD Million)
7.4.2 Market size, by modality, 2017 - 2028 (USD Million)
7.4.3 Market size, by product, 2017 - 2028 (USD Million)
7.4.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by modality, 2017 - 2028 (USD Million)
7.4.5.2 Market size, by product, 2017 - 2028 (USD Million)
7.4.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.4.6 China
7.4.6.1 Market size, by modality, 2017 - 2028 (USD Million)
7.4.6.2 Market size, by product, 2017 - 2028 (USD Million)
7.4.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.4.7 India
7.4.7.1 Market size, by modality, 2017 - 2028 (USD Million)
7.4.7.2 Market size, by product, 2017 - 2028 (USD Million)
7.4.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2017 - 2028 (USD Million)
7.5.2 Market size, by modality, 2017 - 2028 (USD Million)
7.5.3 Market size, by product, 2017 - 2028 (USD Million)
7.5.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by modality, 2017 - 2028 (USD Million)
7.5.5.2 Market size, by product, 2017 - 2028 (USD Million)
7.5.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by modality, 2017 - 2028 (USD Million)
7.5.6.2 Market size, by product, 2017 - 2028 (USD Million)
7.5.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.6 MEA
7.6.1 Market size, by country, 2017 - 2028 (USD Million)
7.6.2 Market size, by modality, 2017 - 2028 (USD Million)
7.6.3 Market size, by product, 2017 - 2028 (USD Million)
7.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by modality, 2017 - 2028 (USD Million)
7.6.5.2 Market size, by product, 2017 - 2028 (USD Million)
7.6.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by modality, 2017 - 2028 (USD Million)
7.6.6.2 Market size, by product, 2017 - 2028 (USD Million)
7.6.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
Chapter 8 Company Profiles
8.1 Strategy dashboard, 2021
8.2 Abbott
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Convergent Technologies GmbH & Co KG
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Sensa Core
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Edan Instruments, Inc
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Erba Mannheim
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 F Hoffmann-La Roche Ltd
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Instrumentation Laboratory (Werfen)
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Medica Corporation
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 OPTI Medical
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Radiometer
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 Siemens AG
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 Nova Biomedical
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
8.14 Tecom Analytical Systems
8.14.1 Business overview
8.14.2 Financial data
8.14.3 Product landscape
8.14.4 Strategic outlook
8.14.5 SWOT analysis
